Both types of interventions are required urgently, because the BCG vaccine does not offer optimal safety and the existing treatment regimens for tuberculosis require at least six months medication. This encourages the advancement of multi-medication resistant strains, as sufferers often do not total the full treatment. Related StoriesGenvoya authorized as total regimen for HIV treatmentBrown University researchers describe new solution to check HIV mutationsSafe, effective douche-centered rectal microbicide can prevent HIV in gay menDr Beate Kampmann, from the Wellcome Trust Center for Clinical Tropical Medication and the Division of Paediatrics at Imperial College London, and among the authors of the study, said: ‘These results describe a novel mechanism whereby Mycobacterium tuberculosis communicates with the individual immune system.today announces that it has completed crucial analysis in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition. Laboratories at the Texas Biomedical Study Institute in San Antonio Texas possess demonstrated complete in-vitro inhibition of the live Ebola Virus stress Zaire at concentrations of CB008 that are achievable by oral administration. CB008 is one of a family group of prescription medications which has been demonstrated by Canopus BioPharma to possess potential in preventing Hemorrhagic syndrome and inhibiting Ebola Viral replication. Related StoriesStudy provides novel insight in to the development of hepatitis A virus and how it spreads to humansMedStar Washington Hospital Center's Ebola Response Team recognized with 2015 Patient Protection AwardJohns Hopkins doctors urge people to obtain vaccinated against influenza virusCB008 can be an in-house codename for a well-established prescription drug first approved by the FDA in the first 1980's for other medical indications.